Spring Conference April 2024 Speaker Slides
Larry Callahan, Lead Scientist – Substance Registration System, FDA
Focus on Ontologies – Clinical Operations
Cameron Gibbs, Ontologist, Crownpoint Technologies
Aditya Tyagi, Project Manager, Pistoia Alliance
Focus on Ontologies – CMC (ISA88) Process Ontologies
Cameron Gibbs, Ontologist, Crownpoint Technologies
Birthe Nielsen, Project Manager, Pistoia Alliance
RAVEN – AI Generated Molecules in Drug-like Space
Mark Griffiths, Senior Data and Knowledge Scientist, AbbVie
AI Revolution in Healthcare: Trends Shaping the Future of Medicine
Sridevi Nagarajan, Head Digital Regulatory Strategy, AstraZeneca
Using Human Genetics and Genomics Data for Systematic Drug Target Identification and Prioritisation
Ellen McDonagh, Translational Informatics Director, Open Targets
Max Petersen, Lab Data Automation Practice Manager, Zifo
Ontologies & LLMs – Democratising Scientific Data
Joe Mullen, Director Data Science & Professional Services, SciBite
The R(e)volution of Digital Health
Bruce Press, Principal, and Adam Schneider, Director of Strategy & Operations, R&D, ZS Associates
IDMP – Ontology Ready Survey, Key Findings
Melih Tuzunoglu, Project Manager, Pistoia Alliance
Heiner Oberkampf, Managing Director, ACCURIDS
Shelia Elz, Master Data Manager, Bayer
Dominik Gigli, Management Consultant, MAIN5
Co-ordinating Efforts to Address RWD Challenges
Lianna Ishihara, Senior Director Real World Data Strategy and Partnerships, GSK
Navigating the Transition: From Models to Deployed AI in Life Sciences R&D
Swetabh Pathak, Co-founder & CTO, Elucidata
From Data Strategy to Delivery: Conciliating Scientists’ Data Needs with Business Consultants,
Felipe Albrecht, Senior Scientist, Roche
Enabling Life Sciences Research with OHDSI, Open Source Standards and Tools
Gregory Klebanov, CEO, Odysseus Data Services
Unlocking the Potential of Real World Data through Federated Data Networks
Michel Van Speybroeck, Director Data Sciences, J&J Innovative Medicines
Differentiating “Value” in the Real World to Drive Competitive Advantage
Vaneet Nayar, Sr Director RWE: Access Consulting, Parexel
Nicolas Fur, Head of Controlled Substance Program, Novartis Pharma
Zofia Jordan, Consultant, ChemAxon
Unlocking Hidden Blocks: Leveraging User-Centred Approaches in Digital Dransformation
Julie Morrison, President/BOD, RockStep Solutions
Driving AI in BioPharma through a New Generation of Public/Private Partnerships
Angeli Moller, Head of DIGI (Data and Integrations Generating Insights), Roche
